Ph1/2 Study to Investigate PKs of CRB-701 Nectin-4 with Solid Tumors
Phase I/II Clinical Trial
A Phase 1/2 Study to Investigate the Safety Pharmacokinetics and Efficacy of CRB-701 an Antibody Drug Conjugate Targeting Nectin-4 in Patients with Advanced Solid Tumors (CRB-701-01)